journal article·2021-05Open access

Monitoring Reversible Tight Junction Modulation with a Current‐Driven Organic Electrochemical Transistor

Katharina Lieberth, Maximilian Brückner, Fabrizio Torricelli, Volker Mailänder, Paschalis Gkoupidenis, Paul W. M. Blom

Advanced Materials Technologies· Volume 6· Issue 5

Abstract

Abstract The barrier functionality of a cell layer regulates the passage of nutrients into the blood. Modulating the barrier functionality by external chemical agents like poly‐l‐lysine (PLL) is crucial for drug delivery. The ability of a cell layer to impede the passage of ions through it and therefore to act as a barrier, can be assessed electrically by measuring the resistance across the cell layer. Here, an organic electrochemical transistor (OECT) is used in a current‐driven configuration for the evaluation of reversible modulation of tight junctions in Caco‐2 cells over time. Exposure to low and medium concentrations of PLL initiates reversible modulation, whereas a too high concentration induces an irreversible barrier disruption due to nonfunctional tight junction proteins. The results demonstrate the suitability of OECTs to in situ monitor temporal barrier modulation and recovery, which can offer valuable information for drug delivery applications.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Conducting polymers and applications · Electrochemical Analysis and Applications · Neuroscience and Neural Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Max Planck Institute for Polymer Research Ackermannweg 10 Mainz 55128 Germany

Dermatology Clinic University Medical Center of the Johannes Gutenberg‐University Mainz Langenbeckstr. 1 Mainz 55131 Germany

Department of Information Engineering University of Brescia Via Branze 38 Brescia 25123 Italy

References (59)

Show source-provided references
1. 10.1007/BF0187142010.1007/BF01871420 ↗
2. 10.1016/j.bbamem.2008.09.01610.1016/j.bbamem.2008.09.016 ↗
3. 10.1096/fj.07-8319com10.1096/fj.07-8319com ↗
4. 10.1016/S0960-9822(00)80105-010.1016/S0960-9822(00)80105-0 ↗
5. Ingels F. · J. Pharm. Belg. · 2002 · 57 · 153
6. 10.1681/ASN.V106133710.1681/ASN.V1061337 ↗
7. 10.1016/0955-0674(93)90024-K10.1016/0955-0674(93)90024-K ↗
8. 10.1152/physiologyonline.2001.16.3.12610.1152/physiologyonline.2001.16.3.126 ↗
9. Matter K. · Int. Rev. Cytol. · 1999 · 1861 · 117
10. 10.1083/jcb.103.1.7110.1083/jcb.103.1.71 ↗
11. 10.1091/mbc.e11-09-079110.1091/mbc.e11-09-0791 ↗
12. 10.1021/mp200572t10.1021/mp200572t ↗
13. 10.1038/s12276-018-0126-x10.1038/s12276-018-0126-x ↗
14. 10.1006/scdb.2000.017710.1006/scdb.2000.0177 ↗
15. 10.1016/0005-2736(93)90159-W10.1016/0005-2736(93)90159-W ↗
16. 10.1111/j.1748-1716.1993.tb09597.x10.1111/j.1748-1716.1993.tb09597.x ↗
17. 10.1016/S0168-3659(97)00154-510.1016/S0168-3659(97)00154-5 ↗
18. 10.1211/jpp.58.10.000510.1211/jpp.58.10.0005 ↗
19. 10.1016/0378-5173(92)90353-410.1016/0378-5173(92)90353-4 ↗
20. 10.1042/bj348055710.1042/bj3480557 ↗
21. 10.1093/toxsci/51.1.11910.1093/toxsci/51.1.119 ↗
22. 10.1016/S0955-2863(01)00208-X10.1016/S0955-2863(01)00208-X ↗
23. 10.1002/adma.20140170610.1002/adma.201401706 ↗
24. 10.3390/bios301004410.3390/bios3010044 ↗
25. 10.1002/adma.20120261210.1002/adma.201202612 ↗
26. 10.1177/221106821456102510.1177/2211068214561025 ↗
27. 10.1002/admt.20190020710.1002/admt.201900207 ↗
28. 10.1006/excr.2000.491910.1006/excr.2000.4919 ↗
29. 10.1002/adhm.20190121510.1002/adhm.201901215 ↗
30. 10.2144/04374ST0310.2144/04374ST03 ↗
31. 10.1002/adhm.20130063210.1002/adhm.201300632 ↗
32. 10.1016/j.bbagen.2012.12.00310.1016/j.bbagen.2012.12.003 ↗
33. 10.1002/adfm.20060123910.1002/adfm.200601239 ↗
34. 10.1002/adma.20130308010.1002/adma.201303080 ↗
35. 10.1126/sciadv.140025110.1126/sciadv.1400251 ↗
36. 10.1038/natrevmats.2017.8610.1038/natrevmats.2017.86 ↗
37. 10.1557/mrc.2017.3410.1557/mrc.2017.34 ↗
38. 10.1002/adbi.20170016410.1002/adbi.201700164 ↗
39. 10.1002/adma.20150367410.1002/adma.201503674 ↗
40. 10.1038/ncomms1544810.1038/ncomms15448 ↗
41. 10.1126/sciadv.150113610.1126/sciadv.1501136 ↗
42. 10.3390/s9120989610.3390/s91209896 ↗
43. 10.1016/j.snb.2019.12676110.1016/j.snb.2019.126761 ↗
44. 10.1039/C5TB00922G10.1039/C5TB00922G ↗
45. Tria S. A. · J. Visualized Exp. · 2014 · 84 · 51102
46. 10.1002/adma.20130261510.1002/adma.201302615 ↗
47. 10.1063/1.490687210.1063/1.4906872 ↗
48. 10.1038/s41467-018-03932-310.1038/s41467-018-03932-3 ↗
49. 10.1002/adhm.20190012810.1002/adhm.201900128 ↗
50. 10.1109/JSSC.2006.88655610.1109/JSSC.2006.886556 ↗
51. 10.1165/ajrcmb.11.2.804907910.1165/ajrcmb.11.2.8049079 ↗
52. 10.1289/ehp.94102106810.1289/ehp.941021068 ↗
53. 10.1023/A:101618831239910.1023/A:1016188312399 ↗
54. 10.1080/10717544.2016.121244010.1080/10717544.2016.1212440 ↗
55. Sitterley G. · BioFiles · 2008 · 3 · 12
56. 10.1002/jps.2101010.1002/jps.21010 ↗
57. 10.1016/j.actbio.2018.03.00610.1016/j.actbio.2018.03.006 ↗
58. Christ B. · Springer Sci.+Business Media LLC · 2017 · 1601 · 111
59. 10.1186/1471-2164-15-70010.1186/1471-2164-15-700 ↗